Variant report

Variant	rs4803799
Chromosome Location	chr19:45655486-45655487
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:21)
CpG islands
(count:0)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:21 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr19:45655340-45655490	GM12867	blood:	n/a	n/a
2	E2F6	chr19:45655175-45657423	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr19:45655340-45655490	GM12872	blood:	n/a	n/a
4	GABPA	chr19:45655169-45656476	H1-hESC	embryonic stem cell:	n/a	n/a
5	POLR2A	chr19:45655365-45656375	A549	lung:	n/a	n/a
6	MAX	chr19:45655239-45657363	H1-hESC	embryonic stem cell:	n/a	chr19:45657081-45657091
7	MXI1	chr19:45654849-45658095	IMR90	lung:	n/a	chr19:45657939-45657948 chr19:45657937-45657946
8	GABPA	chr19:45654975-45656327	H1-hESC	embryonic stem cell:	n/a	n/a
9	MXI1	chr19:45655414-45657598	SK-N-SH	brain:	n/a	n/a
10	POLR2A	chr19:45655429-45655932	GM12878	blood:	n/a	n/a
11	CREB1	chr19:45655414-45656269	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr19:45655340-45655490	HCPEpiC	choroid plexus:	n/a	n/a
13	MAX	chr19:45655290-45657356	H1-hESC	embryonic stem cell:	n/a	chr19:45657081-45657091
14	POLR2A	chr19:45655329-45656481	GM12878	blood:	n/a	n/a
15	POLR2A	chr19:45655413-45655654	H1-hESC	embryonic stem cell:	n/a	n/a
16	POLR2A	chr19:45654157-45655573	K562	blood:	n/a	n/a
17	POLR2A	chr19:45653572-45656097	SK-N-MC	brain:	n/a	n/a
18	POLR2A	chr19:45655268-45655618	HUVEC	blood vessel:	n/a	n/a
19	POLR2A	chr19:45655259-45656957	GM12878	blood:	n/a	n/a
20	STAT5A	chr19:45655331-45655638	GM12878	blood:	n/a	n/a
21	E2F6	chr19:45655264-45657260	H1-hESC	embryonic stem cell:	n/a	n/a

No data

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:45655086..45657605-chr19:45680853..45682730,2	MCF-7	breast:
2	chr19:45654421..45658397-chr19:45679888..45682724,3	K562	blood:
3	chr19:45640971..45644367-chr19:45655076..45659170,3	K562	blood:
4	chr19:45654179..45655741-chr19:45656257..45658728,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000267037	TF binding region
ENSG00000104866	Chromatin interaction
ENSG00000179846	Chromatin interaction
ENSG00000189114	Chromatin interaction
ENSG00000007255	Chromatin interaction

Extended variants
information (count: 12 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:3)

rs_ID	r²[population]
rs10412988	0.97[ASN][1000 genomes]
rs73034821	0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs999559	0.83[AMR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:9 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv912142	chr19:45570051-45708758	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	36 gene(s)	inside rSNPs	diseases
2	nsv833842	chr19:45593888-45684308	Bivalent Enhancer Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	33 gene(s)	inside rSNPs	diseases
3	nsv833843	chr19:45593888-45793682	Weak transcription Strong transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Active TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases
4	nsv912143	chr19:45624303-45767214	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
5	esv3403042	chr19:45626786-45874859	Weak transcription Enhancers Strong transcription Bivalent Enhancer Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	44 gene(s)	inside rSNPs	diseases
6	nsv912144	chr19:45636319-45687446	Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
7	nsv522341	chr19:45640124-45664218	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Weak transcription Enhancers Bivalent/Poised TSS Strong transcription ZNF genes & repeats Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	17 gene(s)	inside rSNPs	diseases
8	esv1795888	chr19:45650386-45681988	Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	20 gene(s)	inside rSNPs	diseases
9	esv3347313	chr19:45654737-45657285	Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:100 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:45627600-45655600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
2	chr19:45639800-45656800	Weak transcription	K562	blood
3	chr19:45650000-45655800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr19:45650200-45655600	Weak transcription	H9 Cell Line	embryonic stem cell
5	chr19:45650800-45656800	Weak transcription	Dnd41	blood
6	chr19:45651800-45660200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
7	chr19:45653000-45655600	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
8	chr19:45654000-45655600	Enhancers	HMEC	breast
9	chr19:45654000-45656000	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr19:45654200-45656000	Bivalent Enhancer	Stomach Mucosa	stomach
11	chr19:45654400-45655600	Bivalent Enhancer	Fetal Muscle Leg	muscle
12	chr19:45654400-45655600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
13	chr19:45654600-45655800	Enhancers	Gastric	stomach
14	chr19:45654600-45657200	Bivalent Enhancer	Fetal Intestine Small	intestine
15	chr19:45654600-45658000	Bivalent Enhancer	Placenta	Placenta
16	chr19:45654800-45655600	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr19:45654800-45655600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
18	chr19:45654800-45655600	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
19	chr19:45654800-45655800	Bivalent Enhancer	Spleen	Spleen
20	chr19:45654800-45656000	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
21	chr19:45654800-45656000	Enhancers	Pancreas	Pancrea
22	chr19:45654800-45656200	Weak transcription	A549	lung
23	chr19:45654800-45656400	Bivalent Enhancer	Lung	lung
24	chr19:45654800-45657200	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
25	chr19:45654800-45657200	Weak transcription	Hela-S3	cervix
26	chr19:45654800-45657400	Bivalent Enhancer	Fetal Brain Male	brain
27	chr19:45654800-45660400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr19:45655000-45655600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr19:45655000-45655600	Enhancers	Primary T helper cells PMA-I stimulated	--
30	chr19:45655000-45655600	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
31	chr19:45655000-45655600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
32	chr19:45655000-45655600	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
33	chr19:45655000-45655800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
34	chr19:45655000-45655800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
35	chr19:45655000-45655800	Bivalent Enhancer	Fetal Stomach	stomach
36	chr19:45655000-45656000	Bivalent Enhancer	Esophagus	oesophagus
37	chr19:45655000-45656000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
38	chr19:45655000-45656000	Bivalent Enhancer	Fetal Thymus	thymus
39	chr19:45655000-45656200	Bivalent Enhancer	Fetal Intestine Large	intestine
40	chr19:45655000-45656800	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
41	chr19:45655000-45656800	Bivalent Enhancer	NHLF	lung
42	chr19:45655000-45657400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr19:45655000-45657400	Enhancers	Fetal Heart	heart
44	chr19:45655000-45657400	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
45	chr19:45655000-45657600	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr19:45655200-45655600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
47	chr19:45655200-45655600	Bivalent Enhancer	Adipose Nuclei	Adipose
48	chr19:45655200-45655600	Bivalent Enhancer	Brain Hippocampus Middle	brain
49	chr19:45655200-45655600	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
50	chr19:45655200-45655600	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links